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White matter hyperintensities (WMHs) of the brain are important markers of aging and small-vessel disease. WMHs are rare in healthy
children and, when observed, often occur with comorbid neuroinflammatory or vasculitic processes. Here, we describe a complex 4 kb
deletion in 2q36.3 that segregates with early childhood communication disorders and WMH in 15 unrelated families predominantly
from Southeast Asia. The premature brain aging phenotype with punctate and multifocal WMHs was observed in ~70% of young carrier
parents who underwent brain MRI. The complex deletion removes the penultimate exon 3 of TM4SF20, a gene encoding a transmem-
brane protein of unknown function.Minigene analysis showed that the resultant net loss of an exon introduces a premature stop codon,
which, in turn, leads to the generation of a stable protein that fails to target to the plasmamembrane and accumulates in the cytoplasm.
Finally, we report this deletion to be enriched in individuals of Vietnamese Kinh descent, with an allele frequency of about 1%,
embedded in an ancestral haplotype. Our data point to a constellation of early language delay andWMH phenotypes, driven by a likely
toxic mechanism of TM4SF20 truncation, and highlight the importance of understanding and managing population-specific low-fre-
quency pathogenic alleles.Introduction
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healthy individuals in their 20s and 30s3,4 and are infini-
tesimal (~1%) in a neurologically healthy pediatric popula-
tion.5 Conversely, in pathological conditions such as pedi-
atric systemic lupus, causing occlusive vascular disease,
WMHs are reported in almost 50% of children, primarily
in the subcortical frontal regions.6 Children with unex-
plained cognitive and/or developmental delay also have
white matter signal abnormalities in an estimated 17%–
26% of cases.7–9 Although the imaging appearance of
white matter pathology in such cases may be nonspecific
and suggestive of injury resulting from prematurity, hyp-
oxia, ischemia, or fetal-maternal infection,10 WMHs are
never considered innocuous findings when observed in
the pediatric age group.11–13
In a genomic study of 15,493 children referred to the
Medical Genetics Laboratories (MGL) at Baylor College of
Medicine (BCM) (Houston, TX), by using 180,000 oligonu-
cleotide-based whole-genome exon-focused array compara-
tive genomic hybridization (CGH),14 we identified a 4 kb
deletion at 2q36.3 that removed the penultimate exon 3 of
TM4SF20 in 12 unrelated individuals with language delay
and WMHs (penetrance of ~70%). With two other indepen-
dent study groups (group 2, Vietnamese ethnicity, Texas
Children’s Hospital, n ¼ 76; group 3, Vietnamese ethnicity,
Signature Genomics, n¼ 171), we confirmed the segregation
of the deletion allele with familial WMHs and disorders of
communication. We show that this highly penetrant 4 kb
deletion cosegregates with WMHs and early childhood lan-
guage delay in multiple families extending from Burma to
Micronesia. We present evidence to illustrate that this popu-
lation-specific deletion with allele frequency of ~1% causes
truncation of the cognate protein and is associated with
communication disorders, with near complete penetrance
in the Vietnamese, Thai, Burmese, Filipino, Indonesian,
and Micronesian pediatric subpopulations. We also demon-
strate that the frequency of WMHs related to TM4SF20 is
significantly higher than that reported in other large pediat-
ric studies of WMHs with unexplained cognitive and/or
developmental delay, suggesting a link between the observed
brain imaging abnormalities and the deletion allele.7–9Subjects and Methods
Subjects
The study was performed in accordance with protocols approved
by the appropriate human subjects ethics committees at Baylor
College of Medicine and each participating institution. Written
informed consents were obtained from the parents of subjects
with the TM4SF20 deletion.Study Group 1: Array CGH at MGL
BetweenMay 2009 and July 2012, 15,493 children of all ethnicities
were studied with the 180,000 oligonucleotide-based whole-
genome exon-focused array CGH for intellectual disability, epi-
lepsy, facial dysmorphisms, congenital heart defects, multiple
congenital anomalies, and/or speech and language delay. The clin-
ical array was performed at the MGL at BCM. Twelve subjects with198 The American Journal of Human Genetics 93, 197–210, August 8the TM4SF20 deletion were evaluated by geneticists, develop-
mental pediatricians, and/or neurologists for language delay and/
or brain imaging abnormalities. Written informed consents were
obtained from the parents of subjects with the TM4SF20 deletion,
identified on the clinical array CGH. Many Southeast Asian fam-
ilies in the study were either refugees (Burmese) or young Viet-
namese immigrants to the United States. Vietnamese and Burmese
language interpreters were employed for recruitment of the non-
English-speaking families. The first and second degree relatives of
the probands were enrolled whenever available and written
informed consents were obtained.
DNA was extracted from whole blood by the Puregene DNA
Blood Kit (Gentra) according to the manufacturer’s instructions.
The procedures for DNA digestion, labeling, and hybridization
for the oligo arrays were performed according to the manu-
facturers’ instructions. Array CGH was performed with V8 OLIGO
custom-designed genome-wide array with approximately 180,000
interrogating oligonucleotides manufactured by Agilent Technol-
ogies as previously described.14,15 The clinical array is designed
by the MGL at BCM with exon-by-exon coverage for about
1,700 genes and 700 microRNAs to detect intragenic single exon
deletions and duplications.
The clinical array includes tiling coverage of mitochondrial
genome and provides whole-genome coverage at the resolution
of 30 kb. Log2 ratios were analyzed for copy-number change via
circular binary segmentation16 to minimize the possibility for
false-negative results; we performed postprocessing of the oligo
level data to ensure all copy-number variation (CNV) events
comprise at least three oligos with consistent median log-ratios.
Long-Range Polymerase Chain Reaction and
Sequencing
Long-range PCR (LR-PCR) reactions were performed to amplify the
predicted junction fragments in the breakpoint regions in
TM4SF20 deletion carriers according to the manufacturer’s specifi-
cations (Takara Bio). The 1 kb junction fragment of the deletion
was amplified by LR-PCR with primers forward 50-ACAAGCA
TAAGCCATTTGAGATCAACTAGTCC-30 and reverse 50-CAACA
GAACTGGAGTAAGTATGAAGCAGTCG-30. The PCR products
were purified with the PCR Purification Kit (QIAGEN) and
sequenced (Lone Star).
Brain Magnetic Resonance Imaging
Brain MRI of all 32 subjects with the deletion (14 unrelated chil-
dren, 13 carrier parents, and 5 related individuals) was performed
at 1.5 T or higher with 5 mm slice thickness. Sequences included
sagittal T1-weighted imaging, axial T2-w imaging, and T2-w FLAIR
imaging acquired in all subjects, in addition to diffusion-weighted
imaging and gradient echo imaging. Each case was evaluated by at
least two neuroradiologists, blinded to the other’s radiological
interpretation and the genetic data.
Linkage Analysis
Families TM200, TM800, TM900, TM1000, TM1100, and 017-1
were evaluated for linkage. Two-point parametric linkage analysis
was performed with MLINK of the FASTLINK package.17 An
autosomal-dominant mode of inheritance and a disease allele fre-
quency of 1% were used in the analysis. For the language delay
phenotype, a fully penetrant model with a phenocopy rate of
0.05 was used. The phenocopy rate of 5% was selected because
this was approximately the prevalence of language delay in the, 2013
general population. For the WMH phenotype, a reduced pene-
trancemodel was used with a penetrance of 0.7. Because of the rar-
ity of this phenotype in healthy children, no phenocopies were
incorporated in the model.
Determination of TM4SF20 Deletion Haplotype
To set phase of the haplotype on which the TM4SF20 deletion is
segregating, trios (mother, father, child) from five families segre-
gating the TM4SF20 deletion were genotyped with either the
Omni 2.5-8 or Human Omni Express arrays from Illumina per
manufacturer’s instruction. One family was of Vietnamese origin,
one Filipino, and three families were of Burmese ancestry. Geno-
types for 139 SNPs typed across all individuals and spanning
500 kb across TM4SF20 were used to determine haplotypes by
family inheritance patterns.
Assessment of Deletion Frequency in Worldwide
Populations
Population-based data were obtained from genotyping 2,089 Viet-
namese Kinh cord blood samples, initially recruited and utilized as
controls in a study of genetic susceptibility to dengue fever.18 The
2,089 cord blood controls were genotyped with the Illumina
Human 660W Quad BeadChips according to the manufacturer’s
instructions. After exclusions resulting from quality control (relat-
edness and genome-wide genotyping success rate), SNP genotype
data from 2,018 Vietnamese Kinh (1,022 males, 996 females) were
available for analysis. Genotypes, log R ratio (LRR), and B allele fre-
quency (BAF) for each probeset were determined with the Illumina
BeadStudio software.
The Illumina Human 660W Quad BeadChip array contains one
SNP in the deletion of interest, rs10933181. Genotype plus LRR
and BAF for this SNP were used to infer the presence or absence
of the deletion in each individual, a genotype and a BAF (>0.97
or <0.01) that was consistent with a homozygous call and a logR
ratio that was less than two SDs from the mean LRR for
rs10933181 in this cohort. Subsequently, each individual sus-
pected of having the deletion based on these criteria (n ¼ 53)
plus an additional 72 samples were genotyped by PCR assay, as
described above, in order to confirm the TM4SF20 deletion status
for each individual. A total of 46 out of 53 individuals typed pos-
itive for the deletion by PCR and one of these 53 subjects was
equivocal. The 72 samples that were negative for deletion by
SNP data were also negative by PCR assay. In summary, the perfor-
mance of the SNP array-based assay for assessment of the TM4SF20
deletion showed sensitivity¼ 1, specificity¼ 0.92, positive predic-
tive value ¼ 0.87, and negative predictive value ¼ 1 in this cohort.
The frequency of this deletion in worldwide populations was
based on data from the 1000 Genomes Project variant calls from
the callset released 2012-02-14.
Generation of DNA Constructs for In Vitro Studies
A minigene construct (gDNA-DEX3) to assay mRNA splicing was
generated by PCR amplification from genomic DNA harboring
the TM4SF20 deletion with the forward primer beginning at
the 50 end of exon 2 and the reverse primer at the stop codon
of exon 4. This fragment was cloned into pCR8/GW-TOPO
(Invitrogen), sequence confirmed, and recombineered into
pcDNA6.2-N-EmGFP (Invitrogen) with LR clonase II (Invitrogen).
The WT protein expression construct was generated by amplifi-
cation of the full-length TM4SF20 open reading frame (ORF) from
whole human brain cDNA (QUICK-clone, Clontech); the DEX3The Amerconstruct was generated by amplification of the partial TM4SF20
ORF (exons 1 and 2) from whole human brain cDNA with the
introduction of a stop codon in the reverse primer. Both WT and
DEX3 pCR8/GW constructs were recombineered into pcDNA6.2-
N-EmGFP (Invitrogen) with LR clonase II (Invitrogen).Cell Culture and Immunostaining
mRNA Splicing Assay
HEK293-FT cells were seeded in 6-well plates, and at 70% conflu-
ency, 1 mg pcDNA6.2-N-EmGFP-gDNA-DEX3 was transfected
with X-tremeGENE transfection reagent (Roche). Cells were har-
vested in Trizol (Invitrogen) at 48 hr after transfection subsequent
to either 8 hr of treatment with Emetine (100 mg/ml) or no treat-
ment. We generated oligo-dT-primed cDNA with Quantitect
reverse transcriptase (QIAGEN), PCR amplified TM4SF20 accord-
ing to standard procedures, and Sanger sequenced PCR products.
Protein Localization
Neuro-2a cells were seeded on glass coverslips in 6-well plates and
were transfected with 1 mg pcDNA6.2-N-EmGFP-WT or 1 mg
pcDNA6.2-N-EmGFP-DEX3 with Dharmafect1 transfection re-
agent (Dharmacon). Cells were fixed with cold methanol at
24 hr after transfection and immunolabeled with a-tubulin anti-
body (Sigma; 1:500), mouse secondary antibody conjugated to
Alexa Fluor 568 (Invitrogen; 1:1,000), and nuclei were stained
with 10 mg/ml Hoeschst 3342 (1:1,000, Invitrogen). Confocal
images were visualized with a Nikon Eclipse 90i microscope and
C1 confocal scanner controlled by EZ-C1 v.3.10 software (Nikon).
Confocal images were acquired at 603, 1.4OD objective, and 5 mm
z-stack.Results
Study Group 1: Array CGH at MGL
By using 180,000 oligonucleotide-based whole-genome
exon-focused array CGH14 in 15,493 children referred to
the MGL at BCM, we identified an ~4 kb deletion at
2q36.3 that removed the penultimate exon 3 of TM4SF20
(RefSeq accession number NM_024795.3) in 12 unrelated
individuals (Figures 1A, 1B, and 2A). Group 1 had diverse
ethnic distribution and wide-ranging referral indications,
including facial dysmorphisms, congenital cardiovascular
malformations, multiple congenital anomalies, intellec-
tual impairment, and/or speech and language delay (Table
S1 available online). The index case, individual TM101 (II-
1 in Figure 1A) was a 3-year-old Burmese boy, referred for
evaluation of language delay and left-sided hemiparesis.
His brain MRI showed bilateral periventricular confluent
WMHs with a thin corpus callosum. The same deletion
was also found in his 35-year-old, apparently healthy, Bur-
mese mother, TM102 (I-2 in Figure 1A) However, her brain
MRI subsequently showed similar multifocal T2 hyperin-
tensities in the periventricular and subcortical deep white
matter of both cerebral hemispheres, suggestive of cerebral
small-vessel disease with mild diffuse cerebral and cere-
bellar volume loss. This identical deletion was observed
in 11 other unrelated pediatric subjects, all of whom
shared a diagnosis of communication disorder, ranging
from early language delay to autism spectrum disorder.ican Journal of Human Genetics 93, 197–210, August 8, 2013 199
Figure 1. Identification of TM4SF20 Exon 3 Deletion in Multiple Families Predominantly of Southeast Asian Descent
(A) BrainMRI study in family TM100 is highlighted, revealing hyperintensities on axial T2-weighted spin echo and confirmed on axial T2
FLAIR, consistent with foci of gliotic changes, and observed in the periventricular and deep subcortical white matter (marked with long
white arrow) in the carrier child (II-1) andparent (I-2). Thematernal brainMRI images (TM102) are shownat the top, and the images of the
proband are illustrated below. Comparison is made with the age-matched normal corresponding MRI image. Note the thin corpus cal-
losum (cc) in TM101. Generous biparietal extra-axial CSF spaces with mild diffuse volume loss is observed in the carrier parent (marked
with short white arrow). Note the prominent Virchow-Robin (VR) spaces highlighted by the yellow arrow.
(B) Fourteen additional pedigrees are shown. Positive sign indicates presence of the deletion and negative sign highlights absence of the
deletion.
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Figure 2. TM4SF20 Heterozygous Deletion and Breakpoint Analysis
(A and B) High-resolution array CGH analysis revealed a 4 kb deletion within 2q36.3 involving exon 3 of TM4SF20 (UCSC Genome
Browser build GRCh37/hg19: 228,230,759–228,234,864).
(C and D) Long-range PCR analysis identified a common 1 kb junction fragment in all the affected subjects. Sequence analysis revealed a
complex rearrangement with a 2.3 kb deletion with microhomology of GT at the first junction, followed by a neutral copy number re-
gion of approximately 100 bp (marked as gray bar-interrupted green), then a 1.7 kb deletion with insertion of a T at the second junction.
(E) The haplotype on which the TM4SF20 deletion segregates was determined for one Vietnamese, one Filipino, and three Burmese fam-
ilies. A haplotype of 30 kb (bracket labeled A, red) was found to be shared across all families. A longer haplotype of 90 kb (bracket labeled
B, green) was shared between the Burmese and Filipino families. Burmese families shared a longer 467 kb haplotype (bracket labeled C,
blue). All SNPs typed in these individuals and utilized in haplotype analyses are shown as black tick marks and the SNPs delineating
haplotypes are labeled. RefSeq genes for this region are shown.
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None of them had any significant facial dysmorphisms or
other congenital anomalies. Driven by the discovery of
this genetic lesion, we performed systematic brain MRI in
other children with the deletion and in all, found punctate
WMHs in the deep whitematter with enlarged perivascular
(VR) spaces to multifocal T2 hyperintensities in the peri-
ventricular white matter in 8 out of 11 pediatric subjects
(72%) imaged (TM101, TM301, TM501, TM601, TM801,
TM1101, TM1301, and TM1401) (Figure 3; Table 1). The
parents declined brain imaging studies for TM1201. Inter-
estingly, most children with the 4 kb TM4SF20 deletion
originated from Southeast Asia or the Far East, including
Burma, Vietnam, Philippines, Thailand, Indonesia, and
Micronesia (Table 1). TM301 was reported to be Hispanic
and TM1301 was of unspecified Asian origin. We noted
that the frequency of WMHs in this group was signifi-
cantly higher than previously reported for healthy chil-
dren between the ages of 1 month and 18 years (p ¼
2.589 3 1011),5 and 3- to 4-fold higher than reported
for children with unexplained intellectual disability with
IQ< 70 (p¼ 1.9663 104)7 or those with idiopathic devel-
opmental delay (p ¼ 2.922 3 103)9 from large studies
(Table S2). In addition, the presence of punctate andmulti-
focal T2 hyperintensities in the periventricular and deep
white matter in 8/10 unrelated carrier parents similar to
those observed in the affected children strongly suggested
a link between the observed brain imaging abnormalities
and the deletion allele (Table 2). Children exposed to early
hypoxic or infectious insult sometimes demonstrate
nonspecific T2 hyperintensities on brain imaging, but the
extent of the findings and the consistency across unrelated
families from a distinct geographical region strongly sug-
gested that these were related to the shared deletion allele.
In further support of this, of all the 15,493 cases (all ethnic-
ities) studied for the deletion allele, the variant was
observed only in those individuals referred for evaluation
of developmental delay, speech/language impairment,
and/or brain imaging abnormalities (n ¼ 6,390) and not
in those with craniofacial dysmorphisms, congenital car-
diovascular malformations, multiple anomalies, musculo-
skeletal concerns, urogenital abnormalities, and other
concerns (n ¼ 9,103) (Table S1). The difference in the fre-
quency of deletion allele in these two classes of phenotypes
is highly significant (p ¼ 1.7 3 106), suggesting that the
deletion is distinct to individuals with communication dis-
orders and brain imaging abnormalities in this group.
Detection of a Complex Genomic Rearrangement
LR-PCR in children and their carrier parents’ genomic DNA
yielded an ~1 kb deletion-specific junction fragment (Fig-
ures 2B–2D). Subsequent sequencing revealed a complex
rearrangement consisting of a 2.3 kb deletion with a GT
microhomology at the first junction and a 1.7 kb deletion
with insertion of a T at the second junction; both deletions
are separated by a neutral copy-number genomic segment
of approximately 100 bp that is oriented directly with
respect to the reference human genome sequence (UCSC202 The American Journal of Human Genetics 93, 197–210, August 8Genome Browser GRCh37/hg19) (Figure 2C). The identical
complex rearrangement in these unrelated pediatric sub-
jects suggested that the deletion occurred on a single
ancestral haplotype and was not due to recurrent de
novo events secondary to susceptibility to genomic insta-
bility rendered by the innate genomic architecture.
Study Group 2: Brain MRI Study of 76 Children of
Vietnamese Origin from Texas Children’s Hospital
To investigate further the potential role of this gene in lan-
guage delay and WMHs, we reviewed the brain-imaging
studies in an ethnicity-specific independent group of 76
children of Vietnamese descent (group 2), evaluated at
Texas Children’s Hospital in Houston, for speech and
language delay, unexplained developmental delay, and/or
autism spectrum disorder (Figure S1). The two indepen-
dent neuroradiologists blinded to the TM4SF20 deletion
status observed diverse brain imaging abnormalities in
multiple cases, including distinct white matter abnormal-
ities in 19/76 (25%) children. The TM4SF20 deletion was
confirmed by PCR in 4/76 (~5%) cases, three of whom
had distinct white matter signal abnormalities (TM201,
017-1, 18-01) (Table S3). One child (TM701) without the
WMHs was also found to have the deletion. The frequency
ofWMHs in this study was noted to be different in deletion
versus nondeletion cases (p ¼ 0.0461, Fisher’s exact test),
indicating that the deletion carriers were more likely to
have WMHs than the nondeletion carriers. TM201,
017-1, and TM701 were then followed further for family
studies. Parents declined further evaluation of 18-01,
who harbored the deletion with WMHs.
The individual TM201 (III-1 in Figure 1B), one of the
severely affected individuals with the deletion, was born
prematurely at 33 weeks gestation with extensive loss of
periventricular white matter and evidence of stroke in the
posterior cerebral artery (PCA) distribution. Pedigree anal-
ysis identified periventricular subcortical T2 hyperinten-
sities in her otherwise healthy carrier father, TM202 (II-2),
and her paternal aunt, TM206 (II-4), both of whom were
<40 years of age with no cerebrovascular risk factors
(Figure S2). Subject 017-1 (II-1 in Figure 1B) presented at 7
years of age with significant language delay. We subse-
quently found his 5-year-old sibling (II-2) to also harbor
the deletion and exhibit severe language impairment, but
his brain imaging study was within normal limits. Their
37-year-old asymptomatic mother (I-1), who also carried
the deletion, showedmultifocal periventricular and subcor-
tical T2 hyperintensities (Figure S3). Subject TM701 (II-1 in
Figure 1B) with normal brain imaging had early language
delay and was diagnosed with autism spectrum disorder.
Her mother (I-1) was also scanned and had normal brain
imaging, confirmed by two neuroradiologists.
Combining groups 1 and 2, a total of 15 unrelated pedi-
atric subjects with the TM4SF20 deletion were studied
(Table 1). Of the 14 individuals imaged, 10 had WMHs
(~71%). Further, with the exception of two individuals
(TM201 and TM301) with moderate to severe disease,, 2013
Figure 3. Spectrum of WMHs in the Children with TM4SF20 Deletion
T2weighted and fluid-attenuated inversion recovery (FLAIR) sequencemagnetic resonance imaging (MRI) scans of nine unrelated subjects
with TM4SF20 deletion are presented, showing varying degrees of white matter disease observed as punctate T2 hyperintensities in the
subcorticalwhitematter andmultifocal T2hyperintensities in the periventricular anddeepwhitematter of both cerebral hemispheres. Sub-
ject TM201,bornprematurely,has gross enlargement of the third and lateral ventricleswithnear-complete lossofperiventricularwhitemat-
ter. Subject TM301 has bilateral open lip schizencephaly in the frontal lobes. Prominent perivascular (VR) spaces are seen in TM501.
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Table 1. Clinical Characteristics of Children with TM4SF20 Heterozygous Deletion
No. Patient ID
Study
Group Ancestry Inheritance
Current
Age Gender Gestation
Language and/or
Speech Disordera WMH MRI Study Results
1 TM101 1 Burmese maternal 3 years male term language delay þ periventricular white
matter loss with T2
hyperintensities, not
typical of periventricular
leukomalacia
2 TM301 1 Hispanic/
unknown
unknown
(adopted)
3 years male term moderate to severe
global delay,
nonverbal, epilepsy
þ bilateral open-lipped
schizencephaly and
deformity of the corpus
callosum; right-sided
peridentate nuclear T2
hyperintensity
3 TM401 1 Burmese paternal 7 years male 32 weeks language delay  slight prominence to the
T2 hyperintensity
returned from the
terminal zones in the
bilateral peritrigonal
regions; one or two
prominent VR spaces
4 TM501 1 Burmese paternal 2 years male term language delay,
autism spectrum
disorder
þ prominent VR spaces with
prominence to the
terminal zones with
increased T2
hyperintensity returned
from the periventricular
white matter outlining
the occipital horns with
delays in myelination to
the subcortical U-fibers in
the high parietal regions
5 TM601 1 Thai/Hispanic maternal 4 years male term nonverbal, autism
spectrum disorder
þ two small focal T2
hyperintensities returned
from the bilateral deep
white matter
6 TM801 1 Pakistani/
Filipino
maternal 3 years male term autism spectrum
disorder
þ multifocal punctate T2
hyperintensities returned
from the bilateral fronto-
parietal regions
7 TM901 1 Filipino maternal 2 years female term language delay  normal study
8 TM1001 1 Indonesian/
European
paternal 1 year male term language delay,
global delay
 within normal limits
appearances to the brain
which is incompletely
myelinated, but age
appropriate, with
prominent terminal zones
9 TM1101 1 Burmese paternal 1 year female term language delay þ multifocal subcortical and
deep T2 hyperintensities
returned from all lobes of
both cerebral
hemispheres without
mass effect
10 TM1201 1 Vietnamese/
European
maternal 4 years male term speech and
language disorder
NA MRI not done
11 TM1301 1 unspecified
Asian ancestry
unknown
(adopted)
1 year female term language delay þ symmetric patchy T2
hyperintense signals in
the occipital subcortical
white matter
12 TM1401 1 Micronesian/
European
maternal 13 years male term language delay,
developmental
delay
þ few scattered nonspecific
high T2 FLAIR foci seen
throughout the
subcortical white matter,
most prominently in the
left frontal lobe
(Continued on next page)
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Table 1. Continued
No. Patient ID
Study
Group Ancestry Inheritance
Current
Age Gender Gestation
Language and/or
Speech Disordera WMH MRI Study Results
13 TM201 2 Vietnamese paternal 1 year female 33 weeks severe global delay,
epilepsy
þ near complete agenesis of
the corpus callosum with
evidence for gliotic
change returned in a left
posterior cerebral artery
distribution; ex-vacuo
dilation of the
supratentorial ventricular
system
14 017-1 2 Vietnamese maternal 7 years male term severe language
delay
þ at least one focal T2
hyperintensity returned
from the right posterior
frontal subcortical white
matter
15 TM701 2 Vietnamese maternal 4 years female term language delay,
autism spectrum
disorder
 normal study
Abbreviation is as follows: VR, Virchow-Robin spaces.
aDetails of deficits are as follows. For TM101: receptive language abilities, 3-year-old level; expressive language, 2-year-old level (Preschool Language Scale,
Fourth Edition [PLS-4]). For TM301: general developmental score, 40; communication, 50; cognitive, 50; adaptive behavior, 50 (DP-3). For TM401: deficiencies
in LNF (letter-naming fluency), in PSF (phoneme-segmentation fluency), and in NWF (nonsense-word fluency) (mCLASS: Dynamic Indicators of Basic Early Liter-
acy Skills). For TM501: visual problem-solving skills, DQ 68; language, DQ 43 (Cognitive Adaptive Test/Clinical Linguistic Auditory Milestone Scale). For TM601:
responses exceed cutoffs on autism spectrum disorder questionnaires (Social Communication Questionnaire - Lifetime [SCQ; 2003] form and a Social Responsive-
ness Scale [SRS; 2005] parent form). For TM701: adaptive behavior composite, 68; communication, 54; daily living skills, 75; socialization, 63; motor skills, 94
(Vineland Adaptive Behavior Assessment II Survey Interview). For TM801: expressive communication, standard score 56, age equivalent of 6 months at 19 months
of chronological age; auditory comprehension, standard score of 61, age equivalent of 9 months; total language score 54, percentile rank 1, age equivalent of
7 months (PLS-4). For TM1101: visual problem-solving skills, DQ 87; language, DQ 67; overall developmental quotient is 77. For TM1201: at age 3.1, informal
observation of expressive language skills showed use of up to five single words per sentence to describe, request, and interact communicatively, and the use of
simple question formulation. Prepositions were apparent but frequently omitted. At age 4.4, the expressive Speech Profile results showed an improvement from
the moderate to the mild to moderate level of articulation proficiency. For TM1301: expressive language at 6 months and receptive language at 10 months, when
evaluated at 12 months. For TM1401: 40 point difference between verbal and performance abilities, with verbal scores significantly lower (Peabody Picture Vo-
cabulary Test Fourth Edition [PPVT-4]); Test of Nonverbal Intelligence Second Edition [TONI-2]).the phenotype of most children with the deletion was
consistent with language delay without significant cranio-
facial or other congenital anomalies and with preserved
motor skills. Few hyperpigmented macules were observed
variably within this group. Formal speech/language and
development assessment in the deletion carriers showed
significant discrepancies between verbal and nonverbal
skills (Table 1).
Study Group 3: Vietnamese Group from Signature
Genomics
The study of the 15 ascertained families indicated near-
complete penetrance for early language delay in the pedi-
atric population, with high penetrance of WMHs in
carriers (~70%). To exclude the possibility that this low-
frequency, population-specific deletion allele was a benign
polymorphism in the Vietnamese population, we obtained
unidentified DNA samples from a third independent set,
comprised of 171 pediatric cases of Vietnamese origin
referred to Signature Genomic Laboratories, LLC for array
CGH analysis. Of these, 79 Vietnamese children were
referred for evaluation of communication disorders, devel-
opmental delay, or brain imaging abnormalities. Via LR-
PCR, we determined the TM4SF20 deletion allele in 4
children, all from within this subgroup of 79 (4/79 ¼
0.050), and none in those referred for other concerns
including multiple congenital anomalies, facial dysmor-
phisms, congenital heart defects, or growth failure (0/92).The AmerThus, combining all Vietnamese cases from groups 1
(n ¼ 168), 2 (n ¼ 76), and 3 (n ¼ 171), there were 415 in-
dividuals with a diverse range of phenotypes studied for
the TM4SF20 deletion. In aggregate, we found the deletion
in 10/189 ¼ 0.053 (95% CI 0.026–0.095) cases evaluated
for early language delay, developmental delay, autism spec-
trum disorder, and brain MRI abnormalities, whereas no
deletions were detected in children with congenital heart
defects, multiple congenital anomalies, facial dysmor-
phisms, urogenital or skeletal abnormalities, or other con-
cerns (0/207 ¼ 0.0 [95% CI 0.0–0.018]) (Table S4). The
difference in the frequency of the deletion in these two
groups is statistically significant (p ¼ 5.4 3 104), demon-
strating that the deletion is unique to Vietnamese individ-
uals with communication disorders and brain imaging
abnormalities.Pedigree and Linkage Analysis
These data suggested a causal link between the deletion in
TM4SF20 and WMHs with associated language delay of
variable expressivity. We determined that the early lan-
guage and/or speech delay phenotype was self-reported
by parents in pedigrees TM200, TM900, TM1000,
TM1200, and TM1400 and in siblings of TM1100 and 17-
01 even before the deletion was identified in the probands.
We performed further genetic and phenotypic family
studies by using standardized criteria for early languageican Journal of Human Genetics 93, 197–210, August 8, 2013 205
Table 2. Clinical Characteristics of Parents with TM4SF20 Deletion
No. Parent ID
Study
Group
Carrier
Parent Ancestry Age Comorbidity WMH MRI Study Results
1 TM102 1 mother Burmese 35 years none þ T2 multifocal punctate subcentimeter hyperintensities
returned from the bifronto-parietal subcortical white
matter with dilated VR spaces
2 TM402 1 father Burmese 52 years end-stage liver disease
(alcoholic cirrhosis,
hepatitis C)
þ cerebellar greater than cerebral atrophy with mild
ex-vacuo dilatation of the supraventricular system in
association with one or two subcortical white matter
focal T2 hyperintensities
3 TM502 1 father Burmese 39 years none þ punctate focal 2–3 mm subcortical white matter T2
hyperintensities returned from the high bilateral
posterior fronto-parietal subcortical white matter
4 TM602 1 mother Thai 35 years none þ tiny foci of T2 hyperintensities returned from
predominately the left posterior parietal subcortical
white matter
5 TM802 1 mother Filipino 36 years none þ bilateral fronto-parietal, less than 5 mm subcortical T2
bright white matter hyperintensities
6 TM902 1 mother Filipino 32 years none  normal study
7 TM1002 1 father Indonesian 30 years none þ multifocal punctate T2 hyperintensities returned from
the bifronto-parietal subcortical white matter, slightly
more marked on the right when compared to the left
8 TM1102 1 father Burmese 42 years none  normal study
9 TM1203 1 mother Vietnamese 36 years none þ there are at least 1–2, 3 mm focus of abnormal T2
hyperintensity returned from the subcortical white
matter in the right insular region
10 TM1402 1 mother Micronesia 50 years hypertension þ multiple scattered foci of increased T2 signal throughout
the periventricular white matter
11 TM202 2 father Vietnamese 37 years none þ multifocal punctate T2 hyperintensities returned from
the bilateral fronto-parietal subcortical white matter
12 017-3 2 mother Vietnamese 37 years none þ multifocal punctate, less than 5mm, T2 hyperintensities
returned from the bifronto-parietal subcortical white
matter
13 TM702 2 mother Vietnamese 29 years none  normal study
Abbreviation is as follows: VR, Virchow-Robin spaces.delay, defined as fewer than 50 words or no word combina-
tions between 20 and 34 months of age,19 as well as by
brain imaging studies. In six families (TM200, TM900,
TM1000, TM1100, TM1200, and 017; Figure 1B), we found
the deletion allele to fully segregate with early childhood
language delay. In family TM900, the proband’s mother
(III-2 in Figure 1B), maternal uncle (III-3), and maternal
grandfather (II-1) reported late expressive language devel-
opment, between 3 and 4 years of age prior to the deletion
testing in the proband; all three were found to have the
deletion (Figure S4). These individuals demonstrated
high educational achievement, holding doctorate degrees.
The deletion was not present in the proband’s brother (IV-
2), father (III-1), maternal grandmother (II-2), or maternal
great-grandmother (I-1). The paternal great-grandfather (I-
2) (aged 92 years) declined genetic testing. Brain MRI
studies were carried out in the proband and her 32-year-
old mother, which were essentially normal.
There were six families (TM200, TM800, TM900,
TM1000, TM1100, and 017) who were sufficiently large
for linkage analysis for language delay. Of these families,206 The American Journal of Human Genetics 93, 197–210, August 8only four were informative for WMHs. When the deletion
was tested for linkage at theta ¼ 0, the total LOD score for
these six families for the language delay phenotype was
3.1, whereas the combined LOD score at theta ¼ 0 for
the four families for WMHs (TM200, TM800, TM1000,
and 017) was 0.75. Although the penetrance for language
delay appears to be high (in pediatric cases) with an auto-
somal-dominant mode of inheritance, there is reduced
penetrance for the WMH phenotype.
Overall, we performed brain MRI study in the following
deletion carriers: 14 unrelated children, 13 parents, and 5
related individuals (TM205, TM206, 017-02, TM1103,
and TM1104) from 15 families (Table S5). Abnormalities
consistent with WMHs were observed in 22/32 (~69%)
deletion carriers, indicating a high (but not complete)
penetrance probably due to the deletion allele (Figures S5
and 3). Each case was evaluated by at least two neuroradi-
ologists who were blinded to the radiological interpreta-
tion and the genetic data. An individual was designated
to have WMHs only if the diagnosis was concurred by
two neuroradiologists. Across all individuals studied, the, 2013
radiological interpretation for WMHs was discordant for
only two subjects (TM401 and 17-02); these were both
scored as normal to err on the side of conservative inter-
pretation. The pattern of distribution of the WMHs and
the apparently fixed abnormalities in the young carrier
adult individuals are more suggestive of ischemic injury
resulting from small brain vessel disease as opposed to
demyelination. No overt neurological deficits were ob-
served in the young adult carriers. Neuropsychological
testing was undertaken for a subset of these young appar-
ently healthy carrier parents to assess the impact of
WMHs onmemory, information processing, and executive
functioning. The results suggested mild impairments in
visuospatial functioning, verbal learning, and problem
solving (Table S6).
Diverse Human Populations and 4 kb TM4SF20
Deletion
Taken together, our segregation and linkage data indicated
that the deletion allele is a likely driver of WMHs and lan-
guage delay in the families investigated. We next asked
what the frequency of this allele might be in diverse
human populations, for which we turned to the 1000
Genomes Project20 data set. The individuals (n ¼ 1,092)
in this released call set represent African, European, Indig-
enous American, and Asian populations. The TM4SF20
deletion was not observed in this sampling. However, we
noted that no Southeast Asians were included in this
data set and the sample size of each individual population
conferred limited power to detect variants of very low fre-
quency (~1%). Therefore, we employed array-based SNP
genotyping from 2,018 umbilical cord blood samples
from Vietnamese Kinh infants.18 Kinh is the most com-
mon ethnic group of Vietnam, comprising ~86% of the
population. Strikingly, we found that 46/2,018 (2.3%) indi-
viduals were carriers of the deletion, a finding confirmed in
each case by PCR of the junction fragment, indicating an
allele frequency of 1.1% in the Vietnamese Kinh (46/
4,036, 95% CI ¼ 0.0076–0.0143).
Haplotype Analysis
The enrichment of the deletion in the subjects suggested a
possible founder effect. To determine the haplotype back-
ground on which the TM4SF20 deletion is segregating,
child-parent trios from five families (one Vietnamese
[TM200], three Burmese [TM100, TM400, and TM500],
and one Filipino [TM900] ancestry) were genotyped.
Haplotype phase was established via 150 SNPs spanning
500 kb centered on the deletion.We observed a core haplo-
type of ~30.4 kb that was shared among all individuals
with the deletion (Figure 2E). A longer 90 kb haplotype
was shared among Burmese and Filipino individuals with
the deletion and a haplotype of 467 kb was shared among
the Burmese families studied. This finding of a short shared
haplotype across Southeast Asian populations along with
the unique and complex structure of the deletion suggests
that the TM4SF20 deletion may represent a founder muta-The Amertion that occurred prior to the dispersal of these sub popu-
lations (Figure S6).Functional Studies
Finally, we turned to the question of a possible mechanism
of disease. To test the potential consequences of the
TM4SF20 deletion on mRNA splicing, and given that we
could not detect TM4SF20 message in either human lym-
phocytes or fibroblasts, we deployed a surrogate in vitro
system. We generated a minigene encompassing the
3.2 kb genomic fragment spanning exon 2 through exon
4 by amplifying genomic DNA from an individual
harboring the deletion (Figure 4A). Subsequent to transient
transfection of the deletion construct into HEK293-FT
cells, we cultured cells in the presence or absence of
Emetine (to block nonsense-mediated decay). TM4SF20
RT-PCR studies of cell lysates from either treatment group
yielded a single mRNA splicing product; sequence confir-
mation revealed splicing of the exon 2 splice donor site
with the exon 4 splice acceptor (Figure 4A). This in-frame
deletion of exon 3 introduced a premature stop codon
(p.Met84*) in the terminal exon, resulting in a stable trun-
cated message (Figures 4A and 4B).
TM4SF20 is a member of the 4-transmembrane L6 super-
family, encoding a surface protein with four transmem-
brane domains. These proteins interact with integrins21
to perform roles in cell adhesion, proliferation, and
motility22 and promote angiogenic activities in endothe-
lial cells through VEGF induction.21–23 To test the cellular
effect of the TM4SF20 exon 3 deletion, which encodes
only two of the transmembrane domains, we transfected
Neuro-2a mouse neuroblastoma cells with N-terminal
GFP-TM4SF20 expression constructs and asked whether
the mutant has either a different half-life or localization
compared to WT. We saw no differences in the former
(data not shown). However, in contrast to the full-length
GFP-TM4SF20 that gave the expected localization to the
cell membrane in essentially all transfected cells, truncated
GFP-TM4SF20-DEX3 protein mislocalized consistently to
the cytoplasm (Figures 4B and 4C; minimum 50 trans-
fected cells scored in duplicate experiments).Discussion
Our findings demonstrate a pediatric syndrome character-
ized by a highly penetrant neurobehavioral trait (language
delay) and neuroanatomical abnormality (WMHs), linked
to a low-frequency population-specific single-exon dele-
tion of TM4SF20. We show that the deletion occurs on a
common genetic background with shared haplotype in
the Thai, Burmese, and Vietnamese subpopulations,
implying that this is a founder deletion mutation, present
in each of these Southeast Asian subpopulations demar-
cated by distinct cultural, geographical, and linguistic
traits. Most speech and language disorders are complex
traits with extensive phenotypic and locus heterogeneity.ican Journal of Human Genetics 93, 197–210, August 8, 2013 207
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Figure 4. Molecular and Cellular Consequences of TM4SF20 Exon 3 Deletion
(A) Schematic of the wild-type (WT) andmutant (DEX3) TM4SF20 loci on human chromosome 2; red boxes, coding exons; white boxes,
untranslated regions; dashed lines, intronic sequence; green boxes, deleted regions. Minigene construct to assay the splicing effect of
DEx3; N-terminal GFP was cloned in-frame to a 3.2 kb region spanning exons 2 through 4. Chromatogram of the minigene RT-PCR
product; black arrows indicate position of primers. Exons 2 and 4 are spliced together, introducing a stop codon at the end of exon 2.
(B) Schematic of WTand DEX3 TM4SF20 GFP fusion proteins. Blue, transmembrane domains (TM); black numbers indicate correspond-
ing exons; amino acids abbreviated as AA.
(C) Confocal images of Neuro-2a cells transfected with N-terminal GFP TM4SF20-WT or TM4SF20-DEX3 constructs (green; left panels)
and costained with a-tubulin (red; center panels) 24 hr after transfection. Blue, Hoeschst staining of nuclei; white asterisks, cells depicted
in the insets (far right panels). Scale bars represent 10 mm.Despite strong evidence for genetic susceptibility, only a
few genetic variants have been linked to nonsyndromic
communication deficits in children.24,25 Large epidemio-
logical studies estimate the prevalence of early language
delay in monolingual English-speaking children to be be-
tween 6% and 8%.26,27 In contrast, about 11.68% of Thai
children are reported to have early language delay at 2
years of age.28 Our study implicates this TM4SF20 popula-
tion-specific variant that accounts for a strong effect on
disease susceptibility related to familial language delay in
the Southeast Asian population. Although children with
unexplained cognitive and/or developmental delay report-
edly have white matter signal abnormalities in 17%–26%
cases,7–9 the frequency of WMHs in children of Viet-
namese, Burmese, Thai, Indonesian, Filipino, and Micro-
nesian origin with the TM4SF20 deletion is significantly208 The American Journal of Human Genetics 93, 197–210, August 8higher (~70%) than any of the reported pediatric WMH
studies related to seizures, unexplained intellectual
disability, or idiopathic developmental delay (Table S2).
These data strongly suggest a link between the ancestral
deletion allele and the T2-hyperintense cerebral white
matter lesions. Although our study shows high penetrance
for WMHs in the 15 families with language delay, it re-
mains to be determined whether other asymptomatic
young carrier individuals exhibit T2 hyperintensities on
brain imaging with similar high penetrance.
Functional studies indicate that the deletion deletes an
internal exon and leads to a truncated form of the protein
that is missing two of its four transmembrane domains
and, although stable, accumulates in the cytoplasm. The
combination of linkage (LOD score 3.1), segregation, and
functional data all point to a dominant disorder with, 2013
high penetrance and variable expressivity. TM4SF20 is ex-
pressed in the adult brain in mammals, readily detectable
in the parietal lobe, occipital lobe, hippocampus, pons,
white matter, corpus callosum, and cerebellum (Figure S7).
Tm4sf20-null mice are viable and exhibit a neurobehavio-
ral phenotype with a decreased anxiety-like response dur-
ing open field testing.29 We speculate that the most likely
mechanism of disease is a neurotoxic effect of the trun-
cated protein. Haploinsufficiency is unlikely, as is a domi-
nant-negative mechanism, because we identified a young
parent (TM1203) homozygous for the deletion whose
neuroradiological phenotype was not much different
from the heterozygotes in our study (Figure S5). The
observed cytoplasmic accumulation of mutant protein in
Neuro2A cells is consistent with the genetic model and
argues that a toxic effect of the mutant protein is the
most plausible driver of the phenotype.
As in most penetrant genetic disorders, there is variable
expressivity seen with TM4SF20 deletion. In the two
affected individuals TM201 and TM301 with moderate to
severe disease, the cognitive impairment was accompanied
by other neurological sequelae including spasticity and
epilepsy. Based on the brain imaging studies of 32 individ-
uals, we consider that the significant brain abnormalities
observed in TM201 are compounded by prematurity and
ischemic injury in the left posterior cerebral artery (PCA)
territory. It is unclear at present how the specific white
matter hyperintensities relate to the neurodevelopmental
profile in the carriers. It also remains to be seen whether
the deletion causes microvascular or functional changes
in the brain, responsible for language delay in these chil-
dren. From our study, there is no obvious correlation be-
tween the extent ofWMHs and severity of communication
disorder in children. This is particularly highlighted by the
brain MRI findings in TM1101, an 18-month-old Burmese
female with the deletion, with normal gross motor devel-
opment and a vocabulary of 3 words at 18 months of
age. Her formal speech and language assessment deter-
mined her visual problem-solving skills DQ to be 87, lan-
guage DQ to be 67, and overall developmental quotient
to be 77. Her MRI study showed out-of-proportion
abnormalities with multifocal subcortical and deep T2
hyperintensities returned from all lobes of both cerebral
hemispheres (Figure 3). This study underscores the vari-
ability in the extent of white matter involvement in these
children, varying from 1–2 focal punctate lesions (TM601)
to multifocal lesions observed in multiple individuals with
the deletion.
The white matter findings in the families are suggestive
of remote small vascular insults as opposed to demyelin-
ation. Although these lesions appear to be nonprogressive
in the young parents and probably represent gliosis, the
natural history of WMHs in older carrier individuals re-
mains to be determined. Our data point to additional con-
tributors to the phenotype that modulate penetrance and
expressivity. It will be interesting to evaluate the remaining
wild-type allele in the pediatric subjects, because theThe Amerdeletion could also unmask other deleterious alleles,
although additional extended families would be required
to obtain sufficient statistical power to examine this possi-
bility. It is also likely that other factors might contribute,
including trans genetic modifiers, as well as environmental
factors such as prematurity, aging, exposure to toxins (such
as alcohol), or infectious agents. Althoughmore studies are
needed regarding the natural history of language delay in
the carriers, the data from the parents and extended pedi-
gree analyses suggest that language delay convalesces over
time in most individuals, potentially reflecting compensa-
tory neuronal plasticity. With a 1% allele frequency of this
deletion in the Vietnamese Kinh population, this is a
distinct example of a population-specific allele that under-
lies an apparent common disease trait inherent to a
distinct world population. This deletion can be simply
identified with the PCR-based amplification assay. For
this population, this TM4SF20 allele could be responsible
for early childhood language delay in a substantial number
of the affected pediatric cases. Our findings provide a
framework for the evaluation of larger cohorts of children
with disorders of communication, including autism spec-
trum disorder for this deletion in distinct Southeast Asian
and Far East subpopulations.Supplemental Data
Supplemental Data include seven figures and six tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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